Thirteen-year follow-up of early intervention with an inhaled corticosteroid in patients with asthma

Journal of Allergy and Clinical Immunology

Volumn 124, Issue 6, 2009, Pages 1180-1185

  Haahtela, Tari ^a   Tamminen, Klaus ^a   Kava, Tuomo ^b   Malmberg, L Pekka ^a   Rytilä, Paula ^a   Nikander, Kurt ^c,d   Persson, Tore ^d   Selroos, Olof ^e  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^b NORTH KARELIA CENTRAL HOSPITAL   (Finland)

^c Respironics   (United States)

^d ASTRAZENECA R AND D   (Sweden)

^e Semeco ^*  (Sweden)

Author keywords

Asthma; asthma control; budesonide; early intervention; inhaled corticosteroids; prebronchodilator FEV1; terbutaline

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BUDESONIDE; CORTICOSTEROID; EOSINOPHIL CATIONIC PROTEIN; MYELOPEROXIDASE; TERBUTALINE;

ADULT; ARTICLE; ASTHMA; DISEASE CONTROL; DRUG MEGADOSE; FEMALE; FOLLOW UP; FORCED EXPIRATORY VOLUME; HUMAN; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; METERED DOSE INHALER; NEUTROPHIL COUNT; PRIORITY JOURNAL;

ADMINISTRATION, INHALATION; ANTI-ASTHMATIC AGENTS; ASTHMA; BRONCHODILATOR AGENTS; BUDESONIDE; DOUBLE-BLIND METHOD; FEMALE; FOLLOW-UP STUDIES; HUMANS; LUNG; MALE; MIDDLE AGED; SPUTUM; TERBUTALINE;

EID: 71149099509     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaci.2009.09.036     Document Type: Article

References (26)

1. Peat J.K., Woolcock A.J., and Cullen K. Rate of decline of lung function in subjects with asthma. Eur J Respir Dis 70 (1987) 171-179
2. Lange P., Parner J., Vestbo J., Schnohr P., and Jensen G. A 15-year follow-up study of ventilatory function in adults with asthma. N Engl J Med 339 (1998) 1194-1200
3. O'Byrne P.M., Pedersen S., Lamm C.J., Tan W.C., Busse W.W., and START Investigators Group. Severe exacerbations and decline in lung function in asthma. Am J Respir Crit Care Med 179 (2009) 19-24
4. Bousquet J., Jeffery P.K., Busse W.W., Johnson M., and Vignola A.M. From bronchoconstriction to airways inflammation and remodeling. Am J Respir Crit Care Med 161 (2000) 1720-1745
5. Pauwels R.A., Pedersen S., Busse W.W., Tan W.C., Chen Y.Z., Ohlsson S.V., et al. Early intervention in mild persistent asthma: a randomized double-blind study. Lancet 361 (2003) 1071-1076
6. O'Byrne P.M., Pedersen S., Busse W.W., Tan W.C., Chen Y.-Z., Ohlsson S.V., et al. Effects of early intervention with inhaled budesonide on lung function in newly diagnosed asthma. Chest 129 (2006) 1478-1485
7. Global Initiative for Asthma. Global strategy for asthma management and prevention. 2008. Available at: http://www.ginasthma.com. Accessed February 6, 2009.
8. 2-agonist, terbutaline, with an inhaled corticosteroid, budesonide, in newly detected asthma. N Engl J Med 325 (1991) 388-392
9. Haahtela T., Järvinen M., Kava T., Kiviranta K., Koskinen S., Lehtonen K., et al. Effects of reducing or discontinuing inhaled budesonide in patients with mild asthma. N Engl J Med 331 (1994) 700-705
10. Agertoft L., and Pedersen S. Effects of long-term treatment with an inhaled corticosteroid on growth and pulmonary function in asthmatic children. Respir Med 88 (1994) 373-381
11. Selroos O., Pietinalho A., Löfroos A.-B., and Riska H. Effect of early vs late intervention with inhaled corticosteroids in asthma. Chest 108 (1995) 1228-1234
12. Selroos O., Löfroos A.-B., Pietinalho A., and Riska H. Asthma control and steroid doses 5 years after early or delayed introduction of inhaled corticosteroids in asthma: a real-life study. Respir Med 98 (2004) 254-262
13. American Thoracic Society. Recommendations for standardized procedures for the on-line and off-line measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide in adults and children-1999. Am J Respir Crit Care Med 160 (1999) 2104-2117
14. Metso T., Rytilä P., Peterson C., and Haahtela T. Granulocyte markers in induced sputum in patients with respiratory disorders and healthy persons obtained by two sputum processing methods. Respir Med 95 (2001) 48-55
15. Taylor D.R., Bateman E.D., Boulet L.D., Boushey H.A., Busse W.W., Casale T.B., et al. A new perspective on concepts of asthma severity and control. Eur Respir J 32 (2008) 545-554
16. In: Bousquet J., and Khaltaev N. (Eds). Global surveillance, prevention and control of chronic respiratory disease: a comprehensive approach (2007), World Health Organization, Geneva
17. Haahtela T., von Hertzen L., Mäkelä M., and Hannuksela M. Allergy Programme Working Group. Finnish Allergy Programme 2008-2018-time to act and change the course. Allergy 63 (2008) 634-645
18. Suissa S., Ernst P., Benayoun S., Baltzan M., and Cai B. Low-dose inhaled corticosteroids and the prevention of death from asthma. N Engl J Med 343 (2000) 332-336
19. Adams R.J., Fuhlbrigge A., Finkelstein J.A., Lozano P., Livingston J.M., Weiss K.B., et al. Impact of inhaled antiinflammatory therapy on hospitalization and emergency department visits for children with asthma. Pediatrics 107 (2001) 706-711
20. Haahtela T., Tuomisto L.E., Pietinalho A., Klaukka T., Erhola M., Kaila M., et al. A ten-year asthma programme in Finland: major change for the better. Thorax 61 (2006) 663-670
21. Busse W.W., Pedersen S., Pauwels R.A., Tan W.C., Chen Y.-Z., Lamm C.J., et al. The Inhaled Steroid Treatment As Regular Therapy in Early Asthma (START) study 5-year follow-up: effectiveness of early intervention with budesonide in mild persistent asthma. J Allergy Clin Immunol 121 (2008) 1167-1174
22. O'Byrne P.M., Barnes P.J., Rodriguez-Roisin R., Runnerstrom E., Sandstrom T., Svensson K., et al. A low dose inhaled budesonide and formoterol in mild persistent asthma: the OPTIMA randomized trial. Am J Respir Crit Care Med 164 (2001) 1392-1397
23. Sont J.K., Willems L.N., Bel E.H., van Krieken J.H., Vandenbroucke J.P., and Sterk P.J. Clinical control and histopathologic outcome of asthma when using airway hyperresponsiveness as an additional guide to long-term treatment. The AMPUL Study Group. Am J Respir Crit Care Med 159 (1999) 1043-1051
24. Tukiainen H., Taivainen A., Majander R., Poussa T., Svahn T., Puolijoki H., et al. Comparison of high and low dose of the inhaled steroid, budesonide, as an initial treatment in newly detected asthma. Respir Med 94 (2000) 678-683
25. Laitinen L.A., Laitinen A., and Haahtela T. A comparative study of the effects of an inhaled corticosteroid, budesonide, and a B2-agonist, terbutaline, on airway inflammation in newly diagnosed asthma: a randomized, double-blind, parallel-group controlled trial. J Allergy Clin Immunol 90 (1992) 32-42
26. Panhuysen C.I., Vonk J.M., Koeter G.H., Schouten J.P., van Altena R., Bleecker E.R., et al. Adult patients may outgrow their asthma: a 25-year follow-up study. Am J Respir Crit Care Med 155 (1997) 1267-1272